Abstract
Background:
Immune thrombocytopenic purpura (ITP) is a bleeding disorder characterized by isolated thrombocytopenia, which is related to an autoimmune process. ITP is considered a diagnosis of exclusion.
Cases:
This article presents 3 cases of pregnant women who were previously diagnosed with ITP. These patients showed had platelet counts of <20 × 109/L at prenatal assessments.
Results:
The three patients were managed prenatally by intravenous immunoglobulin (IVIG) to raise their platelet counts before delivery. Two of these patients completed the 5-day course of treatment and delivered at the planned time; the third patient required an emergency cesarean section before she could complete her course of IVIG treatment.
Conclusions:
IVIG treatment is effective for treating severe ITP. IVIG increases platelet count to a good level that can enable a safe delivery without any maternal or fetal complications.
Get full access to this article
View all access options for this article.